How specific are therapeutic monoclonal antibodies?
- 1 April 2006
- journal article
- Published by Elsevier in The Lancet
- Vol. 367 (9516) , 1038-1039
- https://doi.org/10.1016/s0140-6736(06)68396-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Antibody targeted drugs as cancer therapeuticsNature Reviews Drug Discovery, 2006
- Trastuzumab Cardiac Side Effects: Only Time Will TellJournal of Clinical Oncology, 2005
- Biological impediments to monoclonal antibody–based cancer immunotherapyMolecular Cancer Therapeutics, 2004
- Demystified… recombinant antibodiesJournal of Clinical Pathology, 2004
- Antibodies as therapeutic agents: vive la renaissance!Expert Opinion on Biological Therapy, 2003
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Therapeutic antibodies for human diseases at the dawn of the twenty-first centuryNature Reviews Drug Discovery, 2003
- Isolated Limb Perfusion in the Management of Patients With Recurrent Limb Melanoma: An Important but Limited RoleAnnals of Surgical Oncology, 2001
- Genetically Engineered Monoclonal Antibodies for Direct Anti-Neoplastic Treatment and Cancer Cell Specific Delivery of Chemotherapeutic AgentsCurrent Pharmaceutical Design, 2000
- Light activatable antibodies: Models for remotely activatable proteinsNature Medicine, 1996